Prokidney (PROK) Share-based Compensation (2021 - 2026)

Prokidney (PROK) has reported Share-based Compensation for 6 consecutive years, with $39.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 30.56% year-over-year to $39.8 million in Q2 2026; TTM through Jun 2026 was $39.8 million, a 30.56% increase from a year earlier, with the FY2025 full-year figure at $28.7 million, down 81.58% from the prior year.
• Share-based Compensation was $39.8 million for Q2 2026 at Prokidney, up from $38.5 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $52.7 million in Q1 2022 and troughed at -$6.4 million in Q4 2023.
• A 5-year average of $20.1 million and a median of $19.6 million in 2023 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation soared 263330.0% in 2022 and sank 171.25% in 2023, its largest moves.
• Over 5 years, Share-based Compensation stood at $8.9 million in 2022, then slumped by 171.25% to -$6.4 million in 2023, then surged by 209.07% to $6.9 million in 2024, then fell by 17.92% to $5.7 million in 2025, then jumped by 598.35% to $39.8 million in 2026.
• The last three Share-based Compensation figures came in at $39.8 million (Q2 2026), $38.5 million (Q1 2026), and $5.7 million (Q4 2025), per Business Quant data.